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Corneal Dystrophy Adds to the Frustration of a Dry Eye Patient
Abstract 
PURPOSE
This case report highlights how epithelial basement membrane dystrophy 
(EBMD), coupled with dry eye, can contribute to symptoms of unstable vi-
sion and discomfort. This report also reviews corneal dystrophies and offers 
eye care practitioners (ECPs) clinical pearls for identifying key features. 
CASE REPORT
A 62-year-old Caucasian female presented for a dry eye evaluation due to 
fluctuating vision and longstanding ocular discomfort, despite ocular lubri-
cation. Anterior segment examination revealed Meibomian gland dysfunc-
tion (MGD), upper lid margin staining (ULMS) and anterior blepharitis. 
The patient was unaware of a pre-existing EBMD and this lack of knowl-
edge contributed to her frustration concerning her unstable vision, which 
she had solely attributed to her glasses. Management included warm com-
presses for MGD and targeted preservative-free artificial tears for ULMS 
and EBMD. Photographs were essential for educating the patient with 
respect to the irregularities of the ocular surface and its effect on vision. 
This provided a deeper understanding of the multifactorial nature of her 
symptoms.
CONCLUSION
Unstable and/or poor vision is among the main reasons why patients con-
sult ECPs and it can be difficult to identify contributory factors. This report 
highlights that additional chair time may be warranted to educate patients 
on the multifactorial nature of dry eye and the complexities of corneal dys-
trophy.
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INTRODUCTION
Fluctuating vision can be very frustrating for a patient due to its transient and unpredictable nature, which can 
affect daily tasks, such as reading, driving, and computer use. Common factors that may contribute to fluctuat-
ing vision include ocular-surface anomalies (e.g., corneal dystrophy, dry eye), diabetes and hormonal changes (e.g., 
during pregnancy).1 Poor vision may also be due to uncorrected refractive error, ocular media opacity (i.e., corneal, 
lenticular, or vitreal) and retinal conditions.
Dry eye (DE) disease is a widely prevalent condition,2 which is often accompanied by symptoms of ocular discom-
fort and vision disturbances,3 that affects many aspects of a patient’s quality of life.4-6 Fluctuating vision and ocular 
discomfort are major reasons why patients consult eye care practitioners (ECP).2, 7
The cornea needs to remain clear for proper vision. However, in some cases, alterations to any of the layers of the cor-
nea can affect its transparency and ultimately its function. Corneal dystrophies are a group of genetic disorders that 
cause alterations to the cornea and affect its transparency.8, 9 Corneal dystrophies arise from a progressive accumula-
tion of abnormal material in any of the layers of the cornea, without inflammation, infection, or neovascularization.1, 10, 
11 Since most corneal dystrophies follow an autosomal dominant inheritance pattern, the examination of family mem-
bers can be useful for confirming the diagnosis.1, 10, 12, 13 These dystrophies are progressive in nature, bilateral, but not al-
ways symmetrical,1, 9, 11, 12 and, depending on the layer of the cornea affected, may or may not lead to vision changes.10, 11, 13
Traditionally, corneal dystrophies are classified by the anatomical location of the opacity; i.e., anterior (epithelium/
Bowman’s layer), stromal or endothelial. While some are encountered more commonly than others, Table 112-17 sum-
marizes corneal dystrophies according to their effect on vision, which may assist ECPs in differentiating among them. 
Table 1: Corneal Dystrophies 6-11
Tissue Affected Dystrophy Effect on vision
Anterior 
Epithelial Basement Membrane Dystrophy (EBMD) 
(Map-Dot-Fingerprint)
Normal or reduced (sometimes impaired)
Meesmann Dystrophy Not usually affected but may rarely decrease 
Lisch Dystrophy Sometimes impaired (20/25 to 20/40)
Gelatinous droplike corneal dystrophy 
(Familial subepithelial corneal amyloidosis) *
Marked visual impairment 
(reduced in first decade)
Reis-Bücklers Dystrophy 
Progressive visual impairment, 
marked by 2nd - 3rd decade
Thiel-Behnke dystrophy Progressive visual impairment marked 
by 2nd - 3rd decade
Stromal 
Lattice Dystrophy Type 1 
Progressive visual impairment, 
marked by 3rd-4th decade
Lattice Dystrophy Type 2 Vision usually normal until 6th-7th decade
Granular Dystrophy
Vision good < 40 y, progressive visual
impairment afterwards
Macular Dystrophy Severe visual impairment by 3rd-4th decade 
Schnyder Crystalline Dystrophy
Not usually affected 
(but might be occasionally)
Endothelial 
Fuchs Dystrophy
Progressive visual impairment evolving
in marked reduction (worse in the
morning and improves during the day)
Posterior Polymorphous Dystrophy Rarely progressive visual impairment
Congenital Hereditary Endothelial Dystrophy Blurred vision (worse in the morning)
*May also be classified as stromal
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CASE STUDY
This case report describes a symptomatic patient who was frustrated and unclear as to the source of her unstable 
vision and discomfort, which had several etiologies, including DE and corneal dystrophy. 
CASE REPORT
A 62-year-old Caucasian female was referred to a DE clinic due to longstanding symptoms of fluctuating vision 
and DE. Her most recent eye exam was 5 months prior; a refractive change was noted and new glasses were pre-
scribed. Her general health revealed a history of fibromyalgia, rheumatoid arthritis, hypertension, hypothyroidism 
and depression. Medication use included Diovan HCT® (Novartis) for her hypertension, Synthroid® (Abbvie) for 
her thyroid, Xanax® (Pfizer) for her depression, vitamins (E and C) and omega-3 supplements. Her ocular history 
revealed longstanding complaints of DE, fluctuating vision, pain, irritation and a gritty sensation in both eyes. The 
patient also reported dryness of the mouth, throat, and nose; she tested negative for Sjögren’s syndrome. Addition-
ally, macular drusen were noted and age-related macular degeneration (ARMD) was diagnosed, for which she takes 
vitamins (Vitalux®, ALCON) and is being followed by a retinal specialist. Mild nuclear sclerosis (grade 1) was noted 
in both eyes. The patient reported using artificial tears (Systane® ULTRA, ALCON) 8X/day and an ocular ointment 
at bedtime (Liposic® gel, Bausch + Lomb) to address her ocular discomfort. She remained unsatisfied with her vision 
despite her new glasses and continued to report ocular discomfort.
A comprehensive DE evaluation revealed severe symptoms (score of 87.5/100) using the Ocular Surface Disease In-
dex (OSDI) questionnaire. Other tear tests were performed and the results are summarized in Table 2; most values 
were within normal limits. Distance acuities were similar to those reported at the annual eye exam (OD 6/7.5+2; OS 
6/6+2; OU 6/6-1). The near acuity revealed less than optimal results (OD 0.8 M; OS 1.0 M at 40 cm using a near point 
card), which differed from the results at her check-up 5 months previously (OD 0.37; OS 0.50 M at 50 cm).
Table 2: Clinical findings of DE exam 
Tests Clinical Findings
OSDI questionnaire 87.5/100
Osmolarity (TearLab) OD 288 mOsml/L OS 291 mOsml/L
Cotton Thread Test OD 34 mm/15 sec OS 36 mm/15 sec
Tear meniscus height 0.2 mm OU
Eyelid margin Telangiectasia OU
Lashes Cylindrical dandruff OU
Meibomian glands Yellow, liquid secretions, non-linear with missing glands OU
Corneal staining No defects noted OU
Bulbar Conjunctival Staining No defects noted OU
Palpebral Conjunctival Staining ULMS <20% along the full length, OU
Tear Break Up Time (TBUT) OD 3 sec OS 2 sec
Endothelial cell count OD 2367 cells/mm2 OS 2423 cells/mm2 
A detailed anterior segment evaluation revealed redness (telangiectasia) along the eyelid margin, clear gelati-
nous deposits at the base of a few lashes resembling cylindrical dandruff (CD) and several differently shaped 
translucent corneal opacities in both eyes. Epilation was performed on the lashes that had CD and a micro-
scopic evaluation confirmed the presence of Demodex folliculorum, a common lash mite. Meibomian gland 
assessment revealed difficulty with expression along with yellow, liquid secretions. Meibography (Meiboscan, 
5M Keratograph, Oculus) revealed non-linear and partially filled Meibomian glands in all four eyelids. Ocular 
staining revealed upper lid margin staining (ULMS) along the full length of the upper palpebral conjunctiva, 
with a 20% thickness profile (Table 2).
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The corneal opacities varied with respect to both shape and size, and could be described as irregular gray geograph-
ic patches (resembling ground-glass) and clustered, whorl-like patterns resembling a fingerprint (Figs. 1 and 2). 
These were observed under white illumination with an oblique broad beam, but were more evident with fluorescein 
instillation (Fig. 3). No epithelial defects were noted in either eye. While both eyes presented opacities in the pupil-
lary axis, the dystrophy was more advanced in the left eye, which partly contributed to the reduced near acuity. The 
corneal opacities were photodocumented to establish a baseline and to educate the patient. 
Figure 1: Map (below) and Fingerprint (above) corneal opacities apparent in the right eye 
Diagnosis included evaporative DE secondary to MGD, anterior blepharitis secondary to Demodex, and ULMS. Due 
to the clinical presentation of corneal opacities, a primary diagnosis of epithelial basement membrane dystrophy 
(EBMD) was established.
Management for MGD included daily warm compresses using a face towel for 5-10 minutes followed by ocular mas-
sage. Since the patient did not own a microwave, eyelid warming masks were not a feasible option. Consequently, 
patient education was important to explain how the warm face cloth needed to be alternated with another every 1-2 
minutes to maintain heat on the eyelids.18, 19 She was encouraged to continue with omega-3 supplementation. 
The patient was educated on EBMD, including its permanent nature and associated fluctuating vision and the pos-
sibility of recurrent corneal erosions (RCE). Despite this explanation, the patient was still convinced that her sub-
par vision was due to her new glasses. Management was aimed at decreasing the fluctuating vision, reestablishing 
a smooth refractive surface, and limiting friction between the lid and the corneal surface. Hence, a non-preserved 
artificial tear with sodium hyaluronate (I-Drop® Pur Gel, I-Med Pharma Inc.) was recommended at least 4X/day to 
both reduce friction (ULMS) and enhance the tear layer over the irregular ocular surface (EBMD).
Since the patient was distraught over the EBMD and the fact that her dissatisfaction with her vision may be more 
permanent than she had anticipated, a discussion about the anterior blepharitis secondary to Demodex was delayed 
for a follow-up visit 4 months later. 
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Figure 2: Topographical map corneal opacities present centrally in the left eye
Figure 3: Fluorescein staining highlights the geographic patterns of EBMD in the left eye
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The patient was properly counseled on the contributing etiologies of her symptoms, which included discomfort and 
fluctuating vision. Patient education included information on EBMD, dry eyes, cataracts, and ARMD. Although she was 
still disgruntled, the patient left with a better understanding of the causes of her fluctuating vision and ocular discomfort. 
DISCUSSION
This case exemplifies how EBMD, coupled with DE, can contribute to a patient’s symptoms of unstable vision and 
discomfort. Patients typically assume that all vision problems are correctable. However, in this case, the patient 
needed to be properly educated about the multifaceted etiology of her condition, which may not be completely 
resolvable. Patients need to be reminded that several components of the eye are responsible for creating optimal vi-
sion, from the tear film to the retina. Consequently, any disturbances along that path may contribute to poor/unsta-
ble vision. In this case, the tear film, cornea, lens and retina were compromised, and thus extra time was dedicated 
to educate the patient appropriately. The patient’s complaints were focused on fluctuating blurred vision, irritation 
and pain, despite the lack of any apparent RCE and an updated refraction. A brief discussion of corneal dystrophies 
with particular attention to EBMD was necessary for the patient to understand its contribution to overall vision.
EBMD is the most common corneal dystrophy.9, 16 Although EBMD can occur sporadically, there have been some 
cases of autosomal dominant inheritance.9, 14, 20 EBMD is defined by a triad of characteristic corneal changes, notably 
grey geographic patches (referred to as ‘Map’), gray-white round or oblong opacities (‘Dot’), and curvilinear refrac-
tile clustered lines (‘Fingerprint’).15, 21 Hence EBMD has also been described as Map-Dot-Fingerprint dystrophy to 
reflect the patterns observed on the cornea, and may present some or all of these three features.20 Symptoms include 
blurry vision, grittiness, foreign body sensation, and pain (especially during RCE episodes).20, 22, 23
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Histopathology of these opacities reveals thickening of the epithelial basement membrane with abnormal exten-
sions into the overlying epithelium.12, 20 With the use of fluorescein, these elevated areas appear as negative staining 
and contribute to decreased tear-film stability.14, 24 Furthermore, these projections inhibit the normal surface migra-
tion of maturing epithelial cells, resulting in cysts containing cellular debris from the degenerating cells.12 Epithelial 
cells have hemidesmosomes to reinforce their anchoring to the basement membrane. In EBMD, epithelial cells an-
terior to the abnormal basement membrane are unable to form hemidesmosomes, which causes poor adherence.20 
Due to this frail attachment, the epithelial layer can easily be separated, causing RCE in 10% of these patients; 
asymptomatic patients can quickly become severely symptomatic.1, 9, 21
When differentiating between corneal opacities, an ECP will consider age of onset, effect on vision and location and 
appearance of opacities to render a diagnosis. Age of onset is a poor parameter to distinguish between epithelial 
dystrophies as they all typically occur by the first and/or second decade of life.12-14 EBMD, which is an exception, 
appears in early adulthood.12, 14, 16 Although the present patient was an adult, the age of onset was unknown and 
therefore could not be used to help in the differential diagnosis. 
The effect on vision can be used to distinguish between corneal dystrophies (Table 1). Reis-Bücklers and Thiel-
Behnke dystrophies, for example, may be associated with a marked reduction in acuity, while EBMD and Mees-
mann dystrophy have the potential to impact vision.12, 13 However, in this patient, fluctuating vision was a poor dif-
ferentiating indicator because there were other contributing factors, such as DE, cataracts and ARMD. Therefore, 
in her case, anterior and posterior segment photography was warranted along with strict follow-up to best identify 
which condition will progressively affect her vision.
Symptoms of ocular discomfort and pain, which this patient reported, also may occur in DE and corneal dystrophies 
(with the presence of RCE). This patient had no visible RCE at the time of consultation, yet she reported pain, which 
may be linked to her ocular-surface dryness. Furthermore, the possibility of RCE was discussed, along with the as-
sociated abrupt onset of pain, which may occur and prompt consultation. Although RCEs are possible in any of the 
epithelial dystrophies,13, 25 people may not consult an ECP due to the variability in pain sensation and discomfort 
that they may experience. 
Consequently, age of onset, effect on vision, and pain are not reliable indicators for identifying a corneal pathology. 
As a result, the location and appearance of the opacities remain the principal factors in the diagnosis of epithelial 
dystrophies.25 It is unlikely that an average practitioner would have clinical experience with the full scope of corneal 
dystrophies, unless in a corneal specialty practice. Hence, an atlas would be a useful resource for clarifying the clinical 
presentation of opacities. Table 31, 13, 14, 21, 25 provides some clinical pearls to associate characteristic features of corneal 
opacities with the related epithelial dystrophy. The present case represents a typical EBMD, with representative pho-
tographs, in that the clinical presentation included characteristic Map- and Fingerprint-like corneal opacities. 
Table 3: Clinical pearls in identification of epithelial dystrophies3,7,8,13,19
Feature Location Dystrophy
Map (geographic-shaped opacities)
Dot (putty-like opacities), Fingerprint  
(whorl-like clustered lines)
Epithelial/diffuse EBMD
Epithelial vesicle of uniform shape and size
Epithelial/concentrated in the interpalpebral 
region
Meesmann
Feathery and/or flame-shaped opacities and 
optically empty microcysts
Epithelial/diffuse Lisch
Fine reticular opacification  
(linear, ring-like, or alveolar patterns)
Subepithelial/most dense in central or mid-
periphery (extreme periphery is spared)
Reis-Bücklers
Honeycomb patterned opacity
Subepithelial/most dense in central or mid-
periphery (extreme periphery is spared) 
Thiel-Behnke
C A NA D I A N  JO U R NA L  o f  O P T O M E T RY    |    R EV U E  C A NA D I E N N E  D ’O P T O M É T R I E     VO L .  7 9   NO.  4 15
CLINICAL RESEARCHC
EBMD was previously noted in the patient’s chart, however the patient was unaware of the condition and its effects. 
In this case, the lack of knowledge could have contributed to the patient’s frustration regarding her vision. Visual-
ization of her opacities via digital photography was quite effective in solidifying her understanding of the causes 
of her poor vision. This further confirmed that photographs are valuable chair-side educational tools for patients. 
Typically, clinicians do not own anterior segment cameras. However, a smartphone can easily be propped up against 
the oculars of a slit lamp to facilitate anterior segment photography.26
In this patient, DE was evaporative (MGD), frictional (ULMS) and inflammatory (blepharitis). These conditions are 
all attracting interest in the optometric field and little is known about their pathophysiology and management. For 
now, treatment for this patient was limited to artificial tears and warm compresses, and an information sheet was 
provided to increase her understanding and compliance.
CONCLUSION
Visual impairment, whether permanent or not, is very disconcerting to patients. Consequently, an ECP needs to 
take time to educate their patient appropriately on contributory factors that can affect vision, such as corneal dys-
trophies. Although this patient initially presented with frustration regarding her vision and ocular discomfort, pa-
tient education allowed her to gain a better understanding of her conditions, especially with regard to EBMD and 
DE. The use of anterior segment photography proved to be a powerful tool for promoting the patient’s understand-
ing and hopefully improving compliance with the recommended management. l
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